Background The predominance of chloroquine-susceptible falciparum malaria in Malawi
more than a decade after chloroquine's withdrawal permits contemplation of re-introducing …

Background In 1993, Malawi became the first country in Africa to replace chloroquine with
the combination of sulfadoxine and pyrimethamine for the treatment of malaria. At that time …

Objectives In the Gambia, the combination of chloroquine (CQ) and sulphadoxine-
pyrimethamine (SP) has replaced CQ monotherapy for treatment of malaria caused by …

Emphasis on retaining chloroquine as the first-line therapy for Plasmodium falciparum
infections in most of sub-Saharan Africa for as long as it remains effective has resulted in …

Resistance to chloroquine (CQ) in Plasmodium falciparum has reached unacceptably high
levels in many endemic countries. The pre-treatment factors that identify the children who …

Background Plasmodium falciparum malaria is treated with 25 mg/kg of chloroquine (CQ)
irrespective of age. Theoretically, CQ should be dosed according to body surface area …

Chloroquine (CQ) resistance in Plasmodium falciparum contributes to increasing malaria-
attributable morbidity and mortality in Sub-Saharan Africa. Despite a change in drug policy …

Chloroquine-resistant falciparum malaria is a serious problem in much of sub-Saharan
Africa. However, it is desirable to continue to use chloroquine as first-line therapy for …

We report the results of an in vivo antimalarial efficacy study with chloroquine (CQ) and
sulfadoxine/pyrimethamine (SP) conducted between 2003 and 2004 in Koumantou …

Chloroquine (CQ) resistance in Plasmodium falciparum contributes to growing malaria-
attributable morbidity and mortality in sub-Saharan Africa. However, the extent and degree …